Related Experiment Video
Updated: May 23, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
LKB1 mutations and their correlation with LKB1 and Rheb expression in bladder cancer
Hatice Tigli1, Didem Seven, Murat Tunc
1Cerrahpaşa Medical Faculty, Department of Medical Biology, İstanbul University, İstanbul, Turkey.
Abstract:
Although there are extensive studies on the genetics of bladder cancer, several questions remain unanswered. One of the pathways which are altered in bladder cancer is the mTOR signaling pathway. In the present study, we analyzed the expression of Rheb gene and genetic alterations in the LKB1 gene which are the key components of mTOR pathway. Nine exons of the LKB1 gene were analyzed by direct sequencing in 51 bladder cancer patients. To investigate the expression of Rheb and LKB1, real-time quantitative RT-PCR was performed in bladder tumor and normal bladder tissue samples. We did not observed a statistically significant difference in Rheb or LKB1 expression between the tumor and normal tissue samples. We detected a novel missense mutation creating stop codon in a high percent of the tumor samples. Five different single nucleotide substitutions were also observed in the introns. Our results indicate that LKB1 gene may play a role in the progression of bladder cancer.
Insights
Genetic analysis of the LKB1 gene in bladder cancer revealed a novel mutation. While Rheb and LKB1 gene expression showed no significant difference, LKB1 mutations may impact bladder cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The mTOR signaling pathway is frequently altered in bladder cancer.
- Key components of this pathway include the Rheb and LKB1 genes.
- Understanding genetic alterations in these genes is crucial for bladder cancer research.
Purpose of the Study:
- To analyze the expression of the Rheb gene and investigate genetic alterations in the LKB1 gene within bladder cancer.
- To determine the role of LKB1 and Rheb in the mTOR pathway in bladder cancer progression.
Main Methods:
- Direct sequencing of nine exons of the LKB1 gene in 51 bladder cancer patients.
- Real-time quantitative RT-PCR to assess Rheb and LKB1 gene expression in tumor and normal bladder tissues.
Main Results:
- No statistically significant difference in Rheb or LKB1 gene expression was observed between tumor and normal tissues.
- A novel missense mutation leading to a stop codon was detected in a high percentage of tumor samples.
- Five distinct single nucleotide substitutions were identified in the introns of the LKB1 gene.
Conclusions:
- The LKB1 gene, particularly through novel mutations, may play a significant role in the progression of bladder cancer.
- Further research into LKB1 gene alterations is warranted for understanding bladder cancer pathogenesis.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Non-LTR Retrotransposons
Abnormal Proliferation
